Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,734 | 29 | 48.1% |
| Consulting Fee | $60,900 | 21 | 40.8% |
| Travel and Lodging | $13,187 | 48 | 8.8% |
| Food and Beverage | $3,241 | 52 | 2.2% |
| Education | $23.10 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $103,801 | 101 | $0 (2024) |
| Genentech USA, Inc. | $14,499 | 8 | $0 (2018) |
| GENZYME CORPORATION | $8,553 | 8 | $0 (2023) |
| Myovant Sciences Inc. | $6,264 | 6 | $0 (2022) |
| Janssen Biotech, Inc. | $4,562 | 6 | $0 (2023) |
| Advanced Accelerator Applications | $4,516 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,588 | 4 | $0 (2023) |
| PFIZER INC. | $2,058 | 4 | $0 (2023) |
| Seagen Inc. | $1,055 | 1 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $825.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,232 | 23 | Bayer Healthcare Pharmaceuticals Inc. ($24,203) |
| 2023 | $35,112 | 30 | Bayer Healthcare Pharmaceuticals Inc. ($22,575) |
| 2022 | $26,347 | 25 | Bayer HealthCare Pharmaceuticals Inc. ($23,081) |
| 2021 | $3,100 | 2 | Myovant Sciences Inc. ($3,100) |
| 2020 | $8,823 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($5,370) |
| 2019 | $15,633 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($7,487) |
| 2018 | $9,001 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($8,585) |
| 2017 | $26,837 | 30 | Genentech USA, Inc. ($14,099) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $664.90 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $7,620.00 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $488.96 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $165.51 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $78.70 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $77.75 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $209.10 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $205.94 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $768.62 | General |
| Category: Oncology | ||||||
| 08/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $317.50 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $1,905.00 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $630.56 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,741.00 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $1,270.00 | General |
| Category: Oncology | ||||||
| 01/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $44.24 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $1,746.25 | General |
| Category: Oncology | ||||||
| 12/04/2023 | PFIZER INC. | SUTENT (Drug), INLYTA, TORISEL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,900.00 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 212 | 428 | $148,488 | $36,188 |
| 2022 | 4 | 126 | 213 | $86,816 | $21,985 |
| 2021 | 4 | 133 | 360 | $113,842 | $32,892 |
| 2020 | 6 | 169 | 415 | $112,840 | $28,435 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 55 | 129 | $60,168 | $14,873 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 132 | $42,616 | $10,338 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 59 | 121 | $26,380 | $6,394 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 28 | 28 | $17,024 | $3,821 | 22.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 18 | $2,300 | $761.58 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 36 | 83 | $39,254 | $10,123 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 78 | $24,934 | $6,408 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $17,864 | $4,252 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 22 | $4,764 | $1,201 | 25.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 36 | 116 | $46,220 | $14,339 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 54 | 165 | $48,225 | $13,537 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 31 | 67 | $12,362 | $3,082 | 24.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $7,035 | $1,934 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 67 | 269 | $68,864 | $16,283 | 23.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 69 | $24,909 | $6,264 | 25.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 18 | 18 | $9,864 | $2,659 | 27.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 22 | 30 | $5,298 | $2,063 | 38.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 11 | 16 | $1,734 | $713.30 | 41.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 13 | $2,171 | $452.00 | 20.8% |
About Dr. Edwin Posadas, MD
Dr. Edwin Posadas, MD is a Hematology & Oncology healthcare provider based in Burr Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720140270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Posadas, MD has received a total of $149,085 in payments from pharmaceutical and medical device companies, with $24,232 received in 2024. These payments were reported across 152 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,734).
As a Medicare-enrolled provider, Posadas has provided services to 640 Medicare beneficiaries, totaling 1,416 services with total Medicare billing of $119,499. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Burr Ridge, IL
- Active Since 12/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1720140270
Products in Payments
- Nubeqa (Drug) $76,969
- Xofigo (Drug) $25,182
- JEVTANA (Drug) $8,123
- ORGOVYX (Drug) $6,264
- Balversa (Drug) $3,200
- LYNPARZA (Drug) $2,398
- SUTENT (Drug) $1,900
- PADCEV (Biological) $1,055
- NO PRODUCT DISCUSSED (Drug) $633.91
- TECENTRIQ (Biological) $410.00
- AFINITOR (Drug) $34.89
- FRUZAQLA (Drug) $28.88
- LORBRENA (Drug) $15.50
- INLYTA (Drug) $7.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Burr Ridge
Richard Schilsky, Md, MD
Hematology & Oncology — Payments: $33,051
Mouhammed Kelta, M.d, M.D
Hematology & Oncology — Payments: $3,091
Todd Zimmerman, Md, MD
Hematology & Oncology — Payments: $2,998
Brittany Beach
Hematology & Oncology — Payments: $145.82
Dorothy Sipkins, Md, MD
Hematology & Oncology — Payments: $56.93